Segment Reporting (Tables)

12 Months Ended

Dec. 31, 2016

Segment Reporting [Abstract]

Summary Of Restated Segment Gross Profit From Operations

				Net Impact of Standard Cost
	For the Year Ended			Variance Capitalization and			For the Year Ended	Adjusted
Operating Income (Loss)	December 31, 2015		Percent of	Subsequent Recognition			December 31, 2015	Percent of
(dollars in thousands)	As Previously Reported		Revenue	to the Operating Segments			As Adjusted	Revenue
CAG	$	231,642	17.1%	$	1,677	$	233,319	17.2%
Water		44,584	46.0%		168		44,752	46.2%
LPD		24,397	19.2%		2,760		27,157	21.4%
Other		156	0.7%		(293)		(137)	(0.6%)
Unallocated Amounts		(867)	N/A		(4,312)		(5,179)	N/A
Total Company	$	299,912	18.7%	$	-	$	299,912	18.7%
				Net Impact of Standard Cost
	For the Year Ended			Variance Capitalization and			For the Year Ended	Adjusted
Operating Income (Loss)	December 31, 2014		Percent of	Subsequent Recognition			December 31, 2014	Percent of
(dollars in thousands)	As Previously Reported		Revenue	to the Operating Segments			As Adjusted	Revenue
CAG	$	203,536	16.6%	$	(3,002)	$	200,534	16.4%
Water		39,262	41.4%		(348)		38,914	41.1%
LPD		33,788	23.9%		(4,461)		29,327	20.8%
Other		2,479	9.2%		178		2,657	9.9%
Unallocated Amounts		(18,810)	N/A		7,633		(11,177)	N/A
Total Company	$	260,255	17.5%	$	-	$	260,255	17.5%

Summary Of Segment Performance

For the Years Ended December 31,
	CAG		Water		LPD		Other		Unallocated Amounts		Consolidated Total
2016
Revenue	$	1,522,689	$	103,579	$	126,491	$	22,664	$	-	$	1,775,423
Income (loss) from operations	$	301,342	$	45,702	$	18,914	$	884	$	(16,603)	$	350,239
Interest expense, net												(28,393)
Income before provision for income taxes												321,846
Provision for income taxes												99,792
Net income												222,054
Less: Net income attributable to noncontrolling interest												9
Net income attributable to IDEXX Laboratories, Inc. stockholders											$	222,045
Depreciation and amortization	$	64,878	$	3,098	$	5,543	$	4,699	$	-	$	78,218
Expenditures for long-lived assets (1)	$	56,329	$	2,102	$	4,824	$	1,532	$	-	$	64,787
2015
Revenue	$	1,356,287	$	96,884	$	127,143	$	21,578	$	-	$	1,601,892
Income (loss) from operations	$	233,319	$	44,752	$	27,157	$	(137)	$	(5,179)	$	299,912
Interest expense, net												(26,771)
Income before provision for income taxes												273,141
Provision for income taxes												81,006
Net income												192,135
Less: Net income attributable to noncontrolling interest												57
Net income attributable to IDEXX Laboratories, Inc. stockholders											$	192,078
Depreciation and amortization	$	60,715	$	3,188	$	4,367	$	686	$	-	$	68,956
Expenditures for long-lived assets (1)	$	69,371	$	2,781	$	9,110	$	1,659	$	-	$	82,921
2014
Revenue	$	1,223,064	$	94,725	$	141,179	$	26,839	$	-	$	1,485,807
Income (loss) from operations	$	200,534	$	38,914	$	29,327	$	2,657	$	(11,177)	$	260,255
Interest expense, net												(13,700)
Income before provision for income taxes												246,555
Provision for income taxes												64,604
Net income												181,951
Less: Net loss attributable to noncontrolling interest												45
Net income attributable to IDEXX Laboratories, Inc. stockholders											$	181,906
Depreciation and amortization	$	48,740	$	2,553	$	5,144	$	2,451	$	-	$	58,888
Expenditures for long-lived assets (1)	$	49,270	$	2,499	$	4,025	$	4,729	$	-	$	60,523

__________

(1)Expenditures for long-lived assets exclude expenditures for intangible assets. See Note 3 for information regarding acquisitions of intangible assets during the years ended December 31, 2016, 2015 and 2014.  

Summary Of Revenue By Product And Service Category

	For the Years Ended December 31,
		2016		2015		2014
CAG segment revenue:
CAG Diagnostics recurring revenue:	$	1,281,262	$	1,147,026	$	1,039,252
IDEXX VetLab consumables		451,456		396,526		341,407
Rapid assay products		189,122		182,670		165,647
Reference laboratory diagnostic and consulting services		581,067		512,155		479,192
CAG Diagnostics service and accessories		59,617		55,675		53,006
CAG Diagnostics capital - instruments		121,191		98,502		79,993
Veterinary software, services and diagnostic imaging systems		120,236		110,759		103,819
CAG segment revenue		1,522,689		1,356,287		1,223,064
Water segment revenue		103,579		96,884		94,725
LPD segment revenue		126,491		127,143		141,179
Other segment revenue		22,664		21,578		26,839
Total revenue	$	1,775,423	$	1,601,892	$	1,485,807

Schedule Of Revenue By Principal Geographic Area

	For the Years Ended December 31,
		2016		2015		2014
Americas
United States	$	1,089,595	$	980,281	$	848,928
Canada		74,923		69,303		69,743
Latin America		38,872		34,725		34,086
		1,203,390		1,084,309		952,757
Europe, the Middle East and Africa
Germany		80,156		73,395		85,189
United Kingdom		77,671		74,879		74,131
France		51,204		46,972		53,322
Italy		28,907		25,903		28,794
Spain		24,268		19,998		21,566
Switzerland		16,361		15,631		14,544
Netherlands		14,049		11,645		10,643
Other		83,147		79,910		78,201
		375,763		348,333		366,390
Asia Pacific Region
Australia		52,871		49,274		58,448
Japan		51,544		43,171		44,132
China		48,257		40,619		34,674
Other		43,598		36,186		29,406
		196,270		169,250		166,660
Total	$	1,775,423	$	1,601,892	$	1,485,807

Schedule Of Net Long-Lived Assets By Principal Geographic Areas

	December 31,		December 31,
		2016		2015
Americas
United States	$	298,944	$	285,391
Brazil		17,910		8,404
Canada		1,977		1,796
		318,831		295,591
Europe, the Middle East and Africa
United Kingdom		9,127		13,269
Germany		5,040		5,159
Netherlands		5,948		4,425
France		2,428		2,679
Switzerland		2,450		2,831
Other		3,490		2,047
		28,483		30,410
Asia Pacific Region
Japan		2,469		2,210
Australia		4,185		2,135
Other		3,454		2,680
		10,108		7,025
Total	$	357,422	$	333,026